Expert Interview
Discussing implantable Continuous Glucose Monitors (CGMs) for patients with diabetes with a focus on Senseonics' Eversense CGM data
Ticker(s): SENS, ABT, DXCM, MDTInstitution: Washington University in St. Louis
- Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WUSTL.
- Former Director of the Clinical Diabetes Center at Washington University School of Medicine and currently manages diabetes patients in the Endocrine Fellows Clinic
- Research interest in diabetes population research, inpatient diabetes management, and post transplant diabetes.
Please describe your background and patient setting
Added By: ben_adminHow many patients do you manage who utilize a CGM device?
Added By: ben_adminWhat are the most popular CGM devices used today?
Added By: ben_adminWhat is your opinion of the Eversense 365 CGM?
Added By: ben_adminHow likely are you to increase your prescribing of the Eversense CGM after reading the results published at ADA2023?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
